Failure to induce apoptosis via BCL-2 family proteins underlies lack of efficacy of combined MEK and PI3K inhibitors for KRAS mutant lung cancers

Although several groups have demonstrated that concomitant use of MEK and PI3K inhibitors (MEKi/PI3Ki) can induce dramatic tumor regressions in mouse models of KRAS mutant non-small cell lung cancer (NSCLC), ongoing clinical trials investigating this strategy have been underwhelming to date. While e...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hata, Aaron N., Yeo, Alan, Faber, Anthony C., Lifshits, Eugene, Chen, Zhao, Cheng, Katherine A., Walton, Zandra, Sarosiek, Kristopher A., Letai, Anthony, Heist, Rebecca S., Mino-Kenudson, Mari, Wong, Kwok-Kin, Engelman, Jeffrey A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4046322/
https://ncbi.nlm.nih.gov/pubmed/24675361
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-13-3728
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados